Health and Me

Tanya Dutt

Fluoride Removal From Drinking Water Could Trigger Millions More Cavities In US Kids , Study Warns

The debate over adding fluoride to public drinking water is gaining intensity in the United States. Formerly thought of as a great public health success, water fluoridation is being increasingly challenged by intensified concerns and legislative prohibitions in a few states. New evidence, however, published in JAMA Health Forum cautions that dis-fluoridation of community water systems could carry a high price tag — for children's oral health as well as the country's health care system.

Fluoride, a naturally occurring mineral in some foods and groundwater, is referred to as "nature's cavity fighter." Fluoride hardens tooth enamel, the hard, outer layer of the teeth, making them more resistant to the acids formed by bacteria in the mouth that lead to tooth decay. Tooth decay, or dental caries, is still one of the most prevalent chronic illnesses in children and teenagers in the US, impacting millions.

Fluoride was first added to public water in the US in 1945 and has been recognized by the Centers for Disease Control and Prevention (CDC) as being among the 10 greatest public health successes of the 20th century. Fluoridated water gives both systemic and topical protection, the kind that makes teeth more resistant to decay before they even come up through the gums and protects enamel throughout life.

Researchers Dr. Lisa Simon of Brigham and Women's Hospital and Dr. Sung Eun Choi of Harvard School of Dental Medicine recently examined national oral health data to simulate the effect of <span>fluoride removal</span> from US public water supplies. The results are sobering.

They calculate that eliminating fluoride would cause 25.4 million more decayed teeth among children and teens just in five years, while health care expenses would balloon to $9.8 billion. In a decade, those numbers could almost double to 54 million extra decayed teeth and $19.4 billion in dental care costs.

To give it some perspective, the study estimates one additional rotten tooth per three children in the US — a public health regression that's astounding.

Not all populations would share the burden equally. Dr. Simon points to disparities, pointing out that children from poorer backgrounds and from disadvantaged communities would increasingly depend on fluoridated water to help prevent cavities because they have limited access to dental services. Stripping fluoride away would exacerbate oral health gaps.

Currently, approximately two-thirds of the US population is getting fluoridated water, with nearly 40% of children being exposed to optimal levels of fluoride to prevent tooth decay very effectively. Only nearly 1.5% of children have fluoride levels high enough to endanger fluorosis — a cosmetic dental condition that results in mild discoloration of the teeth.

The Canadian city of Calgary provides a cautionary tale. In 2011, Calgary's city government took fluoride out of its public water system amid public outcry. Within a decade, <span>dental health</span> officials noticed a notable increase in cavities in children, leading to the city reinstating water fluoridation in 2021.

This example provides the real-world illustration backing the new study's projections.

<h2>How Fluoride Protects Tooth Decay?</h2>

Cavities result when bacteria in the mouth infect sugars and release acid that destroys tooth enamel. Fluoride acts by incorporating itself into the structure of the enamel, making the enamel resistant to acid attack and able to repair early damage caused by decay.

In infants, fluoride is important even before the eruption of teeth. It gives a systemic effect by making developing teeth in the gums harder by ingestion of fluoride-rich water and food. For adults and older children, fluoride's local action—via toothpaste, mouth rinses, and water—preserves enamel resistance.

The US Department of Health and Human Services now recommends that fluoride in public water be adjusted to 0.7 milligrams per liter, a scientifically proven level to achieve the optimal balance of cavity prevention with minimal fluorosis risk.

Fluoridation is similar to other public health interventions like the addition of iodine to salt or vitamin D to milk, which are intended to avoid widespread deficiencies of nutrients and improve population health.

Yet, political and public opinion changes have prompted legislative measures in certain states such as Utah and Florida prohibiting water fluoridation. Health and Human Services Secretary Robert F. Kennedy Jr. announced in April 2024 that he would recommend that the CDC discontinue the recommendation of fluoride in public water, which further heated the current debate.

<h2>What Are The Alternatives Available?</h2>

Although fears regarding the safety of fluoride have continued in some quarters, the dental and medical communities' consensus is clear: that water fluoridation at recommended concentrations is safe and beneficial. The danger of fluorosis, usually mild and superficial, is small and commonly outweighed by the advantages of prevention of cavities.

For families concerned about dental health without fluoridated water, alternatives include fluoride toothpaste, professional fluoride treatments at the dentist, and fluoride-containing mouth rinses—though these depend on access to dental care and adherence to proper use.

Children under six should not use fluoride mouthwash without dental supervision due to the risk of swallowing.

The economic consequences of rising cavities from fluoride loss are substantial. Treatment expenses for untreated cavities—fillings, root canals, and extractions—can be burdensome on families and health care systems. Untreated dental disease also has an adverse impact on children's quality of life, resulting in pain, infection, eating difficulties, and lost school days.

The projected $9.8 billion in additional dental care costs within five years, escalating to nearly $20 billion over a decade, represents a substantial burden on families, insurance providers, and public health programs.

The fluoride in water debate captures wider public health policy challenges where scientific truth converges with public opinion and politics. As some places consider banning fluoridation, the new study serves as a reminder of the possible unintended effects.

For now, fluoride remains a cornerstone of dental public health in the US and many countries worldwide. Continuing public education on its benefits, addressing misinformation, and ensuring equitable access to dental care remain critical components in safeguarding children’s oral health.

Fluoride's removal from public drinking water may spark a dental emergency for an estimated million American children, resulting in additional cavities and increased health care expenditures. The data from this new study, along with the real-life experience of Calgary, confirms fluoride's central part in preventing tooth decay.

Health Conditions A-Z

health

dental health

fluoride removal

dental cavities in children

water fluoridation us

tooth decay prevention

fluoride health benefits

public water safety

dental care costs us

Inside Minneapolis' Silent Room: A Place That Makes You Question If Silence Heals or Haunts

Add These Ayurvedic Seeds To Your Daily Diet For Vitamin C And Muscle Repair

What Is Liquid Biopsy? New Blood Test That Can Help Detect, Treat Cancer Faster

Health News

Reasons To Do Dancing As A Workout

Why Summer Fruits Are A Great Addition To Your Diet?

What Should You Avoid For Your Bladder?

Lower-Body Exercises For Strong Foundation

Healthy Drinks That Improve Your Digestion

World Tobacco Day: Unexpected Ways Smoking Can Affect You

Seasonal Mood Swings? How Weather Affects Mental Health

Is Calorie Counting Healthy? Dos And Don’ts

Heat-Related Illnesses That You Should Know

Menstrual Hygiene Day: Tips On Period Hygiene

​Add These High Protein Vegetarian Meals To Your Diet​

Top 10 Workouts That Burn Most Calorie

Makhana Season – Healthy &amp; Quick Foxnut Recipes

Monsoon Ahead – Tips On Building Rainy Season Immunity

Do You Have Prickly Heat Rash – Symptoms, Causes And Treatment

Healthy No-Cook Recipes You Can Try

How Do You Calorie Count – Numbers And Nutrients

Unexpected Signs Of Dehydration – Safety And Precaution Measures

Leg Exercises You Can Do At Home To Build Strength

Foods That Promote Skin Elasticity

Must-Do Chest Exercises You Can Try At Home

What Are The Symptoms Of JN.1 COVID-19 Strain?

Why Does Sleeping Become Harder As You Age?

High-Fiber Healthy Drinks You Should Try

10 Dumbbell Exercise Variations For Upper-Body Strength

A Parent’s Guide To Pets: Important Points To Consider For Your Child’s Health

Food Anxiety Is Real – How Your Food Intake Affects Your Anxiety

World Osteoporosis Month: Ways To Strengthen Your Bones

Brain Exercises To Keep You Cognitively Sharp

Easy Recipes To Make When You Don’t Wish To Cook

Physical Signs Of High Cortisol

9 Healthy Plant-Based Protein Rich Dishes To Try

What Happens When You Have Low Blood Pressure?

Throw These Toxic Bathroom Items Away To Protect Your Health

This Is What Cricket Superstar Virat Kohli Eats In A Day

Signs You Are Experiencing Sensory Overload

Shoulder Exercises You Should Do For Defined Shoulders

Best Foods To Eat When You Are Fasting

​Ghee For Ayurveda: Why It Should Be A Part Of Your Diet​

Symptoms Of Ovarian Cancer You Should Know

The debate over adding fluoride to public drinking water is gaining intensity in the United States. Formerly thought of as a great public health success, water fluoridation is being increasingly challenged by intensified concerns and legislative prohibitions in a few states. New evidence, however, published in JAMA Health Forum cautions that dis-fluoridation of community water systems could carry a high price tag — for children's oral health as well as the country's health care system.Fluoride, a naturally occurring mineral in some foods and groundwater, is referred to as "nature's cavity fighter." Fluoride hardens tooth enamel, the hard, outer layer of the teeth, making them more resistant to the acids formed by bacteria in the mouth that lead to tooth decay. Tooth decay, or dental caries, is still one of the most prevalent chronic illnesses in children and teenagers in the US, impacting millions.Fluoride was first added to public water in the US in 1945 and has been recognized by the Centers for Disease Control and Prevention (CDC) as being among the 10 greatest public health successes of the 20th century. Fluoridated water gives both systemic and topical protection, the kind that makes teeth more resistant to decay before they even come up through the gums and protects enamel throughout life.Researchers Dr. Lisa Simon of Brigham and Women's Hospital and Dr. Sung Eun Choi of Harvard School of Dental Medicine recently examined national oral health data to simulate the effect of fluoride removal from US public water supplies. The results are sobering.They calculate that eliminating fluoride would cause 25.4 million more decayed teeth among children and teens just in five years, while health care expenses would balloon to $9.8 billion. In a decade, those numbers could almost double to 54 million extra decayed teeth and $19.4 billion in dental care costs.To give it some perspective, the study estimates one additional rotten tooth per three children in the US — a public health regression that's astounding.Not all populations would share the burden equally. Dr. Simon points to disparities, pointing out that children from poorer backgrounds and from disadvantaged communities would increasingly depend on fluoridated water to help prevent cavities because they have limited access to dental services. Stripping fluoride away would exacerbate oral health gaps.Currently, approximately two-thirds of the US population is getting fluoridated water, with nearly 40% of children being exposed to optimal levels of fluoride to prevent tooth decay very effectively. Only nearly 1.5% of children have fluoride levels high enough to endanger fluorosis — a cosmetic dental condition that results in mild discoloration of the teeth.The Canadian city of Calgary provides a cautionary tale. In 2011, Calgary's city government took fluoride out of its public water system amid public outcry. Within a decade, dental health officials noticed a notable increase in cavities in children, leading to the city reinstating water fluoridation in 2021.This example provides the real-world illustration backing the new study's projections.How Fluoride Protects Tooth Decay?Cavities result when bacteria in the mouth infect sugars and release acid that destroys tooth enamel. Fluoride acts by incorporating itself into the structure of the enamel, making the enamel resistant to acid attack and able to repair early damage caused by decay.In infants, fluoride is important even before the eruption of teeth. It gives a systemic effect by making developing teeth in the gums harder by ingestion of fluoride-rich water and food. For adults and older children, fluoride's local action—via toothpaste, mouth rinses, and water—preserves enamel resistance.The US Department of Health and Human Services now recommends that fluoride in public water be adjusted to 0.7 milligrams per liter, a scientifically proven level to achieve the optimal balance of cavity prevention with minimal fluorosis risk.Fluoridation is similar to other public health interventions like the addition of iodine to salt or vitamin D to milk, which are intended to avoid widespread deficiencies of nutrients and improve population health.Yet, political and public opinion changes have prompted legislative measures in certain states such as Utah and Florida prohibiting water fluoridation. Health and Human Services Secretary Robert F. Kennedy Jr. announced in April 2024 that he would recommend that the CDC discontinue the recommendation of fluoride in public water, which further heated the current debate.What Are The Alternatives Available?Although fears regarding the safety of fluoride have continued in some quarters, the dental and medical communities' consensus is clear: that water fluoridation at recommended concentrations is safe and beneficial. The danger of fluorosis, usually mild and superficial, is small and commonly outweighed by the advantages of prevention of cavities.For families concerned about dental health without fluoridated water, alternatives include fluoride toothpaste, professional fluoride treatments at the dentist, and fluoride-containing mouth rinses—though these depend on access to dental care and adherence to proper use.Children under six should not use fluoride mouthwash without dental supervision due to the risk of swallowing.The economic consequences of rising cavities from fluoride loss are substantial. Treatment expenses for untreated cavities—fillings, root canals, and extractions—can be burdensome on families and health care systems. Untreated dental disease also has an adverse impact on children's quality of life, resulting in pain, infection, eating difficulties, and lost school days.The projected $9.8 billion in additional dental care costs within five years, escalating to nearly $20 billion over a decade, represents a substantial burden on families, insurance providers, and public health programs.The fluoride in water debate captures wider public health policy challenges where scientific truth converges with public opinion and politics. As some places consider banning fluoridation, the new study serves as a reminder of the possible unintended effects.For now, fluoride remains a cornerstone of dental public health in the US and many countries worldwide. Continuing public education on its benefits, addressing misinformation, and ensuring equitable access to dental care remain critical components in safeguarding children’s oral health.Fluoride's removal from public drinking water may spark a dental emergency for an estimated million American children, resulting in additional cavities and increased health care expenditures. The data from this new study, along with the real-life experience of Calgary, confirms fluoride's central part in preventing tooth decay.

fluoride removal from drinking water could trigger millions more cavities in us kids , study warns

Health & Wellness

New Cancer Therapy Increases Survival Rate By 40%: Study

new cancer therapy increases survival rate by 40%: study

Fitness

Exercise Proven ‘Better Than Drugs’ To Prevent Colon Cancer Recurrence, Study Trial Shows

exercise proven ‘better than drugs’ to prevent colon cancer recurrence, study trial shows

Colon Cancer Is Rising In Millennials- But This One Symptom Still Feels Too Embarrassing To Talk About

colon cancer is rising in millennials- but this one symptom still feels too embarrassing to talk about

More Than A Diagnosis: Cancer Survivors Share The Small Wins That Helped Them Heal

national cancer survivors day: 'more than a diagnosis' - cancer survivors share the small wins that helped them heal

Cancer therapy is ever-evolving with new tests, treatments and pills- and in the middle of it is a revolutionary technology known as <span>liquid biopsy</span>. Just to think of a simple blood test that can diagnose cancer in its early stages, predict how a tumor will respond to treatment, and help doctors to change medications before cancer has a chance to develop anew. That's no longer science fiction anymore. Liquid biopsy is transforming the way we detect and treat cancer giving new hope to patients and changing the face of oncology.

Unlike earlier biopsies, in which tissue has to be taken from the tumor itself—usually through surgery or needle biopsies—a liquid biopsy is as easy as a blood test. This blood is then tested for circulating tumor DNA (ctDNA) or shed tumor cells in the blood. These bits contain the genetic material of the tumor and enable physicians to learn about the molecular nature of the cancer without gaining direct access to the tumor.

The latest versions of this test can even identify small, sinister changes in proteins—providing important clues about what a tumor might do and whether it is developing resistance to therapy.

A recent study published in The New England Journal of Medicine which was presented at the American Society of Clinical Oncology annual meeting illustrates just how potent liquid biopsy can be. The study involved individuals with estrogen-fueled metastatic breast cancer—a sub-type that is generally treated with medications that attack specific proteins on cancer cells.

With time, tumors evolve and these mutations can make treatments ineffective. In the research, scientists employed liquid biopsies to identify such protein mutations as far back as nine months prior to when they could be seen on conventional imaging scans. Early detection enabled doctors to change treatments preemptively—radically enhancing outcomes.

We have highly effective treatments, but they have to wear off," said Dr. Nicholas Turner, the study's co-author and a professor of molecular oncology at The Royal Marsden Hospital. "If we can pick up the changes early, we can move quickly—before the cancer does any more damage."

<h2>How Liquid Biopsies Could Enhance Outcomes?</h2>

The research had 315 patients, all of whom had acquired mutations following treatment. The liquid biopsy findings influenced a change in treatment in half of the cohort, with the other half retaining treatment as before.

Patients who had changed their treatment were twice as likely to maintain their tumors at bay in the coming year. Liquid biopsies could identify mutations up to nine months before conventional scans. In 10% of the volunteers, the test showed their treatment was no longer working, before symptoms or scans could detect it.

These results indicate a significant change in the way we monitor cancer and make medication changes—equipping clinicians and patients with sooner insights and more tailored treatment alternatives.

While this most recent study focused on breast cancer, liquid biopsy is being designed for a broad spectrum of cancers. A case in point is lung cancer, where liquid biopsies are already producing results 16 days sooner than traditional tissue biopsies, based on pilot data from the UK's National Health Service (NHS).

This quicker turnaround enables patients to initiate life-extending, targeted treatments sooner—potentially avoiding the lag that allows cancer to develop further.

NHS National Clinical Director for Cancer, Professor Peter Johnson, captured the potential of liquid biopsies perfectly:

"They are taking us into a new age of personalized cancer treatment… and we can see the difference this test is already making."

In 2022, Australian scientists reported in The New England Journal of Medicine that liquid biopsy could predict whether individuals with early-stage colon cancer required chemotherapy following surgery. This enabled numerous patients to safely avoid chemotherapy, sparing them its energy-sapping side effects without sacrificing for treatment effectiveness.

Dr. Jeanne Tie, senior research fellow at the Walter and Eliza Hall Institute of Medical Research in Australia and lead author of the study, underlined that liquid biopsies could soon become routine tools in early cancer treatment and management, but availability still differs around the world.

The secret of this groundbreaking test is its capacity for analyzing ctDNA, or pieces of tumor DNA circulating in the bloodstream. These pieces provide a molecular snapshot of the tumor, exposing important genetic mutations that reveal:

<ul><li>How aggressive the cancer is</li><li>Whether it's responding to current treatment</li><li>Which treatments are most likely to be effective</li></ul>

By detecting these changes earlier, liquid biopsies allow physicians to match patients with targeted treatments—drugs that are customized to a tumor's own individual genetic signature. Chief Scientific Officer for England Professor Dame Sue Hill welcomed this technology, "This technology is revolutionizing care and enabling clinicians to match patients sooner with potentially life-prolonging targeted therapies."

Liquid biopsy is not only a more accurate or quicker test—it's also cheaper and less invasive. One independent health economics review in the UK estimated that liquid biopsies would save the NHS as much as £11 million annually in lung cancer treatment alone.

Moreover, by minimizing the necessity for repeat scans, invasive biopsies, or cycles of unwanted chemotherapy, the test is also improving quality of life for many patients.

As the technology becomes even more advanced, researchers are looking to utilize it for:

<ul><li>Pancreatic and gallbladder cancer</li><li>Monitoring cancer growth and treatment response in real-time</li><li>Screening healthy people for early cancer signs—before symptoms even begin</li></ul>

liquid biopsy

cancer blood test

tumor dna detection

metastatic breast cancer

personalized cancer care

early cancer diagnosis

ctdna testing

Cancer therapy is ever-evolving with new tests, treatments and pills- and in the middle of it is a revolutionary technology known as liquid biopsy. Just to think of a simple blood test that can diagnose cancer in its early stages, predict how a tumor will respond to treatment, and help doctors to change medications before cancer has a chance to develop anew. That's no longer science fiction anymore. Liquid biopsy is transforming the way we detect and treat cancer giving new hope to patients and changing the face of oncology.Unlike earlier biopsies, in which tissue has to be taken from the tumor itself—usually through surgery or needle biopsies—a liquid biopsy is as easy as a blood test. This blood is then tested for circulating tumor DNA (ctDNA) or shed tumor cells in the blood. These bits contain the genetic material of the tumor and enable physicians to learn about the molecular nature of the cancer without gaining direct access to the tumor.The latest versions of this test can even identify small, sinister changes in proteins—providing important clues about what a tumor might do and whether it is developing resistance to therapy.A recent study published in The New England Journal of Medicine which was presented at the American Society of Clinical Oncology annual meeting illustrates just how potent liquid biopsy can be. The study involved individuals with estrogen-fueled metastatic breast cancer—a sub-type that is generally treated with medications that attack specific proteins on cancer cells.With time, tumors evolve and these mutations can make treatments ineffective. In the research, scientists employed liquid biopsies to identify such protein mutations as far back as nine months prior to when they could be seen on conventional imaging scans. Early detection enabled doctors to change treatments preemptively—radically enhancing outcomes.We have highly effective treatments, but they have to wear off," said Dr. Nicholas Turner, the study's co-author and a professor of molecular oncology at The Royal Marsden Hospital. "If we can pick up the changes early, we can move quickly—before the cancer does any more damage."How Liquid Biopsies Could Enhance Outcomes?The research had 315 patients, all of whom had acquired mutations following treatment. The liquid biopsy findings influenced a change in treatment in half of the cohort, with the other half retaining treatment as before.Patients who had changed their treatment were twice as likely to maintain their tumors at bay in the coming year. Liquid biopsies could identify mutations up to nine months before conventional scans. In 10% of the volunteers, the test showed their treatment was no longer working, before symptoms or scans could detect it.These results indicate a significant change in the way we monitor cancer and make medication changes—equipping clinicians and patients with sooner insights and more tailored treatment alternatives.While this most recent study focused on breast cancer, liquid biopsy is being designed for a broad spectrum of cancers. A case in point is lung cancer, where liquid biopsies are already producing results 16 days sooner than traditional tissue biopsies, based on pilot data from the UK's National Health Service (NHS).This quicker turnaround enables patients to initiate life-extending, targeted treatments sooner—potentially avoiding the lag that allows cancer to develop further.NHS National Clinical Director for Cancer, Professor Peter Johnson, captured the potential of liquid biopsies perfectly:"They are taking us into a new age of personalized cancer treatment… and we can see the difference this test is already making."In 2022, Australian scientists reported in The New England Journal of Medicine that liquid biopsy could predict whether individuals with early-stage colon cancer required chemotherapy following surgery. This enabled numerous patients to safely avoid chemotherapy, sparing them its energy-sapping side effects without sacrificing for treatment effectiveness.Dr. Jeanne Tie, senior research fellow at the Walter and Eliza Hall Institute of Medical Research in Australia and lead author of the study, underlined that liquid biopsies could soon become routine tools in early cancer treatment and management, but availability still differs around the world.How Does Liquid Biopsy Work?The secret of this groundbreaking test is its capacity for analyzing ctDNA, or pieces of tumor DNA circulating in the bloodstream. These pieces provide a molecular snapshot of the tumor, exposing important genetic mutations that reveal:How aggressive the cancer isWhether it's responding to current treatmentWhich treatments are most likely to be effectiveBy detecting these changes earlier, liquid biopsies allow physicians to match patients with targeted treatments—drugs that are customized to a tumor's own individual genetic signature. Chief Scientific Officer for England Professor Dame Sue Hill welcomed this technology, "This technology is revolutionizing care and enabling clinicians to match patients sooner with potentially life-prolonging targeted therapies."Liquid biopsy is not only a more accurate or quicker test—it's also cheaper and less invasive. One independent health economics review in the UK estimated that liquid biopsies would save the NHS as much as £11 million annually in lung cancer treatment alone.Moreover, by minimizing the necessity for repeat scans, invasive biopsies, or cycles of unwanted chemotherapy, the test is also improving quality of life for many patients.As the technology becomes even more advanced, researchers are looking to utilize it for:Pancreatic and gallbladder cancerMonitoring cancer growth and treatment response in real-timeScreening healthy people for early cancer signs—before symptoms even begin

what is liquid biopsy? new blood test that can help detect, treat cancer faster

How The Drug 'Creon' Works And Why Its Shortage Is Forcing Cancer Patients To Skip Meals

How The Drug Creon Works And Why Its Shortage Is Forcing Cancer Patients To Skip Meals

Drinking Even In Moderation Can Increase Your Cancer Risk In This Organ, Finds Study

drinking even in moderation can increase your cancer risk in this organ, finds study

Nutrition

This 'Sweet and Sour' Fruit Juice Can Help Ease Sore Throat While Reducing Your Cancer Risk

this unexpected fruit juice can not only help with sore throat but also reduce cancer risk, study suggests

<span>Cancer</span> patients as well as patients with conditions such as cystic fibrosis and chronic pancreatitis are now confronted with an acute shortage of an essential medication—Creon. This pancreatic <span>enzyme replacement therapy</span> (PERT) is crucial to digesting food, one of the most fundamental of human activities which becomes all but impossible for those with pancreatic insufficiency.

The consequences are frightening- patients are forgoing meals, dividing up doses, and driving more than 30 miles just to receive the capsules. The effect is not just nutritional but life-threatening, because not being able to properly digest food can make a person vulnerable to infection, make them weaker, and restrict access to life-saving treatment like chemotherapy.

Creon is the brand name of pancreatic enzyme replacement therapy that is used to manage exocrine pancreatic insufficiency (EPI)—a disease in which the pancreas is unable to produce enzymes to help digest food. This inability can be due to a variety of reasons, such as pancreatic cancer, cystic fibrosis, chronic pancreatitis, and complications after surgery like gastric-bypass or pancreatic surgery.

For individuals with EPI, Creon® is not merely a supportive therapy—it is a lifeline. It allows them to extract nutrition from food and sustain body weight, energy, and immune capacity. Without it, patients experience persistent diarrhea, abdominal pain, malnutrition, and ultimately, reduced quality of life and survivability.

The Government in the UK has prolonged the Serious Shortage Protocol (SSP) for Creon until November 2025, enabling pharmacists to dispense a reduced quantity without a fresh prescription. Although the policy tries to make things more accessible, this is a short-term solution to an ongoing and hazardous shortage.

One survey carried out by the National Pharmacy Association (NPA), surveying more than 300 pharmacies, shows a dire picture. A whopping 96% of these pharmacies are struggling to get Creon, the essential pancreatic enzyme replacement therapy. Additionally, 89% have the same shortages with other drugs like Nutrizym and Pancrex. This shortage is making many patients go distances of over 30 miles just to get a pharmacy that will fill their prescriptions. Even more alarming, many patients are said to be skipping meals or cutting their doses in order to stretch their short supplies, jeopardizing their health and wellbeing in the process.

The shortage is primarily due to "European-wide supply issues" and production limitations on the drug that have caused interruptions in the manufacture and distribution of Creon, as reported by the Department of Health and Social Care. The interruptions are not specific to Creon but point to systemic weaknesses in pharmaceutical production.

In Creon's case, though, the end result is worse. Unlike certain drugs that can be skipped or substituted for others, Creon® is instantly vital with each patient meal. There is no "respite" from taking it, and even temporary discontinuation can cause health emergencies.

<h2>How is the Shortage of the Drug Affecting Cancer Patients?</h2>

The psychological and physical strain on the patients cannot be estimated. As Alfie Bailey-Bearfield, Pancreatic Cancer UK's Head of Influencing &amp; Health Improvement, stressed, "It's completely unacceptable that they are still taking desperate steps which risk their health, wellbeing, and their suitability for treatment."

Patients going without meals in order to cut corners on enzyme capsules put themselves at significant risk of malnutrition and severe weight loss. Not only does this compromise the immune response of the body, it lowers tolerance to chemotherapy, effectively excluding patients from life-sustaining or curative therapy. The medical risk is not abstract—it's real and measurable.

Exocrine Pancreatic Insufficiency (EPI) is more prevalent than many people know. In the UK alone, approximately 61,000 patients need pancreatic enzyme therapy. Reasons are:

<ul><li>Pancreatic cancer (especially advanced)</li><li>Cystic fibrosis</li><li>Chronic and acute pancreatitis</li><li>Pancreatic surgery or gastric bypass</li><li>Untreated celiac disease or inflammatory bowel disease</li></ul>

EPI results in undigested food entering the colon, leading to bloating, gas, cramps, and diarrhea. With time, the nutrient deficiencies cause weight loss, bone loss, and even increased cardiovascular risk. In children, it impairs growth and development.

Unlike regular prescriptions, Creon is not prescribed with a set amount. It has to be individualized for each patient, for each meal, and even for each snack. The dosing is 3,000 to 36,000 enzyme units per capsule. For comparison, a normal pancreas will release up to 720,000 units for a small meal.

Patients are instructed to self-regulate according to their intake, so that a consistent and plentiful source becomes not only the preferred but also the necessary mode of correct dosing. Under shortages, this individualized dosing is a luxury many cannot enjoy.

Healthcare providers and patient advocacy groups alike are demanding immediate government action. Bailey-Bearfield and Picard have issued public calls for a strategic restructuring to solve manufacturing constraints and enhance distribution systems.

"This crisis continues to put people's health at risk, and they cannot afford to wait any longer," Bailey-Bearfield implored.

It takes not only stockpiling but also long-term planning, such as investment in alternative manufacturing hubs, local production incentives, and better global supply chain coordination.

cancer

creon shortage

pancreatic cancer treatment

cystic fibrosis drug

enzyme replacement therapy

cancer patient health

digestive drug crisis

creon availability issues

Cancer patients as well as patients with conditions such as cystic fibrosis and chronic pancreatitis are now confronted with an acute shortage of an essential medication—Creon. This pancreatic enzyme replacement therapy (PERT) is crucial to digesting food, one of the most fundamental of human activities which becomes all but impossible for those with pancreatic insufficiency.The consequences are frightening- patients are forgoing meals, dividing up doses, and driving more than 30 miles just to receive the capsules. The effect is not just nutritional but life-threatening, because not being able to properly digest food can make a person vulnerable to infection, make them weaker, and restrict access to life-saving treatment like chemotherapy.Creon is the brand name of pancreatic enzyme replacement therapy that is used to manage exocrine pancreatic insufficiency (EPI)—a disease in which the pancreas is unable to produce enzymes to help digest food. This inability can be due to a variety of reasons, such as pancreatic cancer, cystic fibrosis, chronic pancreatitis, and complications after surgery like gastric-bypass or pancreatic surgery.For individuals with EPI, Creon® is not merely a supportive therapy—it is a lifeline. It allows them to extract nutrition from food and sustain body weight, energy, and immune capacity. Without it, patients experience persistent diarrhea, abdominal pain, malnutrition, and ultimately, reduced quality of life and survivability.The Government in the UK has prolonged the Serious Shortage Protocol (SSP) for Creon until November 2025, enabling pharmacists to dispense a reduced quantity without a fresh prescription. Although the policy tries to make things more accessible, this is a short-term solution to an ongoing and hazardous shortage.One survey carried out by the National Pharmacy Association (NPA), surveying more than 300 pharmacies, shows a dire picture. A whopping 96% of these pharmacies are struggling to get Creon, the essential pancreatic enzyme replacement therapy. Additionally, 89% have the same shortages with other drugs like Nutrizym and Pancrex. This shortage is making many patients go distances of over 30 miles just to get a pharmacy that will fill their prescriptions. Even more alarming, many patients are said to be skipping meals or cutting their doses in order to stretch their short supplies, jeopardizing their health and wellbeing in the process.The shortage is primarily due to "European-wide supply issues" and production limitations on the drug that have caused interruptions in the manufacture and distribution of Creon, as reported by the Department of Health and Social Care. The interruptions are not specific to Creon but point to systemic weaknesses in pharmaceutical production.In Creon's case, though, the end result is worse. Unlike certain drugs that can be skipped or substituted for others, Creon® is instantly vital with each patient meal. There is no "respite" from taking it, and even temporary discontinuation can cause health emergencies.How is the Shortage of the Drug Affecting Cancer Patients?The psychological and physical strain on the patients cannot be estimated. As Alfie Bailey-Bearfield, Pancreatic Cancer UK's Head of Influencing & Health Improvement, stressed, "It's completely unacceptable that they are still taking desperate steps which risk their health, wellbeing, and their suitability for treatment."Patients going without meals in order to cut corners on enzyme capsules put themselves at significant risk of malnutrition and severe weight loss. Not only does this compromise the immune response of the body, it lowers tolerance to chemotherapy, effectively excluding patients from life-sustaining or curative therapy. The medical risk is not abstract—it's real and measurable.What is EPI?Exocrine Pancreatic Insufficiency (EPI) is more prevalent than many people know. In the UK alone, approximately 61,000 patients need pancreatic enzyme therapy. Reasons are:Pancreatic cancer (especially advanced)Cystic fibrosisChronic and acute pancreatitisPancreatic surgery or gastric bypassUntreated celiac disease or inflammatory bowel diseaseEPI results in undigested food entering the colon, leading to bloating, gas, cramps, and diarrhea. With time, the nutrient deficiencies cause weight loss, bone loss, and even increased cardiovascular risk. In children, it impairs growth and development.Unlike regular prescriptions, Creon is not prescribed with a set amount. It has to be individualized for each patient, for each meal, and even for each snack. The dosing is 3,000 to 36,000 enzyme units per capsule. For comparison, a normal pancreas will release up to 720,000 units for a small meal.Patients are instructed to self-regulate according to their intake, so that a consistent and plentiful source becomes not only the preferred but also the necessary mode of correct dosing. Under shortages, this individualized dosing is a luxury many cannot enjoy.Healthcare providers and patient advocacy groups alike are demanding immediate government action. Bailey-Bearfield and Picard have issued public calls for a strategic restructuring to solve manufacturing constraints and enhance distribution systems."This crisis continues to put people's health at risk, and they cannot afford to wait any longer," Bailey-Bearfield implored.It takes not only stockpiling but also long-term planning, such as investment in alternative manufacturing hubs, local production incentives, and better global supply chain coordination.

how the drug 'creon' works and why its shortage is forcing cancer patients to skip meals

Ishita Roy

COVID-19 Cases In India Continue To Surge, Kerala Tops The List

India Records 3,395 Active COVID-19 Cases, 26 Deaths, Kerala And Maharashtra Among Worst-Hit States

india records 3,395 active covid-19 cases, 26 deaths, kerala and maharashtra among worst-hit states

High PCOS Prevalence Found Among Young Women In Delhi, Finds Study

high pcos prevalence found among young women in delhi, finds study

Cook County Health Grapples With Lost Grants Amid Federal Pullback

cook county health grapples with lost grants amid federal pullback

COVID-19 cases in India continue to rise, the numbers have now touched 3,758. Kerala, the southern-most state in India has reported the highest of the cases, leading with 1,400 cases, followed by Maharashtra with 506 cases. 

On Saturday, the Union Health Ministry released a data, which registered 685 more active cases, another data was released on Sunday, which reported 360 new infections, which had been recorded within 24 hours. 

Apart from that, two COVID-19 deaths were also reported during the same time, in Kerala and Karnataka. In Karnataka, a 63-year-old man who had comorbidities including pulmonary TB, squamous cell carcinoma of buccal mucosa, and was also tested positive for COVID-19, passed away. While in Kerala, a 24-year-old woman with COVID-19 and pre-existing conditions like sepsis, hypertension, and decompensated chronic liver disease (DCLD) also passed away, reported the Health Ministry. 

As per the Ministry of Health and Family Welfare figures, in the last 24 hours, Kerala reported 64 new cases, Maharashtra reported 18, while Delhi reported 61 new cases. 

In Delhi, a 60-year-old woman who had been tested positive with COVID-19 also passed away, as per the official. This has also marked the first death in the capital during the current wave. The woman is said to have undergone surgery for intestinal obstruction, and incidentally found out that she was also COVID-19 positive. 

Gurugram too reported a spike in COVID-19 cases after two and a half years. Dr Alka Singh, who is the Civil Surgeon also urged people to not ignore flu-like symptoms. From the cases reported earlier, it has been found that people who had been suffering from flu were in fact, COVID-19 positive. 

Four new Covid-19 cases were reported in Gurugram on Sunday, bringing the total during the current surge to 23, with 12 active cases. All patients have mild symptoms and are isolating at home. The health department collected 97 samples for testing the same day.

Maharashtra reported 65 new Covid-19 cases on Sunday, bringing the total since January 1 to 814. Pune accounted for 31, Mumbai 22, Thane nine, Kolhapur two, and Nagpur one. The state currently has 506 active cases, with 300 recoveries so far, according to the health department.

<strong>ALSO READ: <a href="https://www.healthandme.com/health-news/india-records-3395-active-covid-19-cases-26-deaths-kerala-and-maharashtra-among-worst-hit-states-article-151765683" data-type="tilCustomLink">India Records 3,395 Active COVID-19 Cases, 26 Deaths, Kerala And Maharashtra Among Worst-Hit States</a></strong>

In Odisha, active cases have risen to 12, all presenting mild symptoms and placed in isolation, said Nilakantha Mishra, the state’s Director of Public Health.

Andhra Pradesh’s information minister K Parthasarathi urged people to remain vigilant amid a national rise in infections, advising caution in crowded public spaces such as railway stations, bus stands, and airports.

West Bengal registered 82 new cases in the past 24 hours, taking the number of active cases in the current wave to 287. Six people were discharged after testing negative. Updated figures from the state health department are awaited.

Punjab has six active Covid-19 cases, with five reported from Ludhiana. One death has occurred. Among the infected are two children of the deceased, who are asymptomatic and in quarantine. The remaining cases include a returnee from Kerala and two individuals who had contact with travellers from high-infection states.

In view of the rising Covid-19 cases, the Karnataka government on Saturday issued an advisory urging the public to wear masks in crowded spaces, maintain physical distancing, and follow hygiene protocols.

Union minister of state for health and AYUSH, Prataprao Jadhav, assured last week that the central government is fully prepared to manage any emerging Covid-19 situation.

COVID 19 cases in India

health news

COVID 19

COVID cases In India

India Covid 19 cases

India news

Incida COVID 19 news

COVID 19 news

COVID-19 cases in India continue to rise, the numbers have now touched 3,758. Kerala, the southern-most state in India has reported the highest of the cases, leading with 1,400 cases, followed by Maharashtra with 506 cases. On Saturday, the Union Health Ministry released a data, which registered 685 more active cases, another data was released on Sunday, which reported 360 new infections, which had been recorded within 24 hours. Apart from that, two COVID-19 deaths were also reported during the same time, in Kerala and Karnataka. In Karnataka, a 63-year-old man who had comorbidities including pulmonary TB, squamous cell carcinoma of buccal mucosa, and was also tested positive for COVID-19, passed away. While in Kerala, a 24-year-old woman with COVID-19 and pre-existing conditions like sepsis, hypertension, and decompensated chronic liver disease (DCLD) also passed away, reported the Health Ministry. As per the Ministry of Health and Family Welfare figures, in the last 24 hours, Kerala reported 64 new cases, Maharashtra reported 18, while Delhi reported 61 new cases. India Impacted By COVID-19In Delhi, a 60-year-old woman who had been tested positive with COVID-19 also passed away, as per the official. This has also marked the first death in the capital during the current wave. The woman is said to have undergone surgery for intestinal obstruction, and incidentally found out that she was also COVID-19 positive. Gurugram too reported a spike in COVID-19 cases after two and a half years. Dr Alka Singh, who is the Civil Surgeon also urged people to not ignore flu-like symptoms. From the cases reported earlier, it has been found that people who had been suffering from flu were in fact, COVID-19 positive. Four new Covid-19 cases were reported in Gurugram on Sunday, bringing the total during the current surge to 23, with 12 active cases. All patients have mild symptoms and are isolating at home. The health department collected 97 samples for testing the same day.Maharashtra reported 65 new Covid-19 cases on Sunday, bringing the total since January 1 to 814. Pune accounted for 31, Mumbai 22, Thane nine, Kolhapur two, and Nagpur one. The state currently has 506 active cases, with 300 recoveries so far, according to the health department.ALSO READ: India Records 3,395 Active COVID-19 Cases, 26 Deaths, Kerala And Maharashtra Among Worst-Hit StatesIn Odisha, active cases have risen to 12, all presenting mild symptoms and placed in isolation, said Nilakantha Mishra, the state’s Director of Public Health.Andhra Pradesh’s information minister K Parthasarathi urged people to remain vigilant amid a national rise in infections, advising caution in crowded public spaces such as railway stations, bus stands, and airports.West Bengal registered 82 new cases in the past 24 hours, taking the number of active cases in the current wave to 287. Six people were discharged after testing negative. Updated figures from the state health department are awaited.Punjab has six active Covid-19 cases, with five reported from Ludhiana. One death has occurred. Among the infected are two children of the deceased, who are asymptomatic and in quarantine. The remaining cases include a returnee from Kerala and two individuals who had contact with travellers from high-infection states.In view of the rising Covid-19 cases, the Karnataka government on Saturday issued an advisory urging the public to wear masks in crowded spaces, maintain physical distancing, and follow hygiene protocols.Union minister of state for health and AYUSH, Prataprao Jadhav, assured last week that the central government is fully prepared to manage any emerging Covid-19 situation.

covid-19 cases in india continue to surge, kerala tops the list

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Fluoride Removal From Drinking Water Could Trigger Millions More Cavities In US Kids , Study Warns

Quick Stories

What Is Liquid Biopsy? New Blood Test That Can Help Detect, Treat Cancer Faster

How The Drug 'Creon' Works And Why Its Shortage Is Forcing Cancer Patients To Skip Meals

COVID-19 Cases In India Continue To Surge, Kerala Tops The List

Health Conditions A-Z

Inside Minneapolis' Silent Room: A Place That Makes You Question If Silence Heals or Haunts

Add These Ayurvedic Seeds To Your Daily Diet For Vitamin C And Muscle Repair

What Is Liquid Biopsy? New Blood Test That Can Help Detect, Treat Cancer Faster